Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Latest filing published 05 Oct 2026 for CORCEPT THERAPEUTICS INC, €3,013. Read the official filing
Filing timeline
BuySaleSean Maduck
Insider track record
Disclosed buys
0
Disclosed sells
18
Signal history
Sean Maduck: trading record in brief
Sean Maduck is a declared insider of Corcept Therapeutics Inc (senior executive), with filings sourced from SEC (Form 4). The record holds 82 filings, for trades running from 15 May 2018 to 2 October 2026.
Every open-market trade on record is a sale: 18 sales worth €18.5M. Besides market trades, the filings include 16 share grants and 45 option exercises. Since January 2026: no purchases and 18 sales on the market.
The newest entry dates from 5 October 2026: an option exercise of €3,013, in Corcept Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sean Maduck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations82 total
413 shares@ US$8.27Common StockSEC:0001193125-26-414674:0
413 shares@ US$115.5373Common StockSEC:0001193125-26-414674:1
24,587 shares@ US$8.27Common StockSEC:0001193125-26-414674:2
15,843 shares@ US$116.1233Common StockSEC:0001193125-26-414674:3
8,744 shares@ US$116.5534Common StockSEC:0001193125-26-414674:4
2,281 shares@ US$115.61180.0021% mcap0.7% of flowCommon StockSEC:0001193125-26-382474:3
150 shares@ US$113.380.0001% mcap0.0% of flowCommon StockSEC:0001193125-26-382474:4
25,000 shares@ US$8.270.0016% mcap0.5% of flowCommon StockSEC:0001193125-26-382474:0
11,730 shares@ US$113.93510.010% mcap3.5% of flowCommon StockSEC:0001193125-26-382474:1
10,989 shares@ US$114.71180.0098% mcap3.3% of flowCommon StockSEC:0001193125-26-382474:2
150 shares0Common StockSEC:0001193125-26-382474:5
117 shares@ US$113.380.0001% mcap0.0% of flowCommon StockSEC:0001193125-26-382474:6
30,955 shares@ US$11.350.0027% mcap4.9% of flowCommon StockSEC:0001193125-26-371388:0
25,085 shares@ US$125.46760.024% mcap43.6% of flowCommon StockSEC:0001193125-26-371388:1
5,870 shares@ US$126.05880.0058% mcap10.2% of flowCommon StockSEC:0001193125-26-371388:2
3,664 shares@ US$8.270.0002% mcap0.4% of flowCommon StockSEC:0001193125-26-355563:0
3,664 shares@ US$114.490.0033% mcap5.9% of flowCommon StockSEC:0001193125-26-355563:1
1,031 shares@ US$8.270.0001% mcap0.0% of flowCommon StockSEC:0001193125-26-346951:0
1,031 shares@ US$114.51820.0009% mcap0.3% of flowCommon StockSEC:0001193125-26-346951:1
20,305 shares@ US$8.270.0013% mcap2.4% of flowCommon StockSEC:0001193125-26-335617:0
20,305 shares@ US$114.70450.018% mcap32.6% of flowCommon StockSEC:0001193125-26-335617:1
2,801 shares@ US$88.51270.0020% mcap0.7% of flowCommon StockSEC:0001193125-26-296296:2
25,000 shares@ US$8.270.0016% mcap0.6% of flowCommon StockSEC:0001193125-26-296296:0
11,024 shares@ US$87.33490.0077% mcap2.6% of flowCommon StockSEC:0001193125-26-296296:1
11,175 shares@ US$89.30940.0080% mcap2.7% of flowCommon StockSEC:0001193125-26-296296:3
25 of 82 declarations
